Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here
Friday, November 4, 2011
Some People with Hepatitis B May Need Liver Cancer Screening Sooner and More Often
Over years or decades, chronic hepatitis B (and C) can lead to serious liver damage including cirrhosis and HCC. In the U.S., hepatitis B is much more prevalent among people from Asia, where HBV is endemic and many people became perinatally infected before the advent of widespread vaccination.